Investing News NetworkYour trusted source for investing success

pieris pharmaceuticals

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Sesen Bio Up 40 Percent

Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy

10 Top Immuno-Oncology Companies

Pieris Pharmaceuticals Announces Public Offering of Common Stock

Pieris Obtains Regulatory Clearance for Clinical Study in Australia

Pieris Reports Financial Results for Q3 2017

Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development

Pieris Pharmaceuticals Appoints Key Executive Positions

Pieris To Collaborate With AstraZeneca

Drilling recommences at Yunndaga

Placement Shares Issued & Drilling Approval Expected August

Completion of Tranche 1 Equity Placement & Cleansing Notice

Homerun Resources Inc. Announces Receipt of a Competitive Budgetary Offer for Latin America's First Dedicated Solar Glass Manufacturing Facility

LaFleur Minerals Engages Bumigeme to Complete Valuation Report on Beacon Gold Mill

Maritime Resources

Triumph Gold

Quimbaya Gold

New Age Exploration

Asara Resources

International Lithium Corp.

MARKETS

COMMODITIES

CURRENCIES